Cargando…

Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype

BACKGROUND: Leucine-rich repeat kinase 2 (LRRK2) is a common gene implicated in Parkinson’s disease (PD) and is also thought to be fundamentally involved in numerous immune functions. Thus, we assessed the role of LRRK2 in the context of the effects of the environmental toxicant, paraquat, that has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudyk, Chris, Dwyer, Zach, Hayley, Shawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554960/ https://www.ncbi.nlm.nih.gov/pubmed/31174552 http://dx.doi.org/10.1186/s12974-019-1483-7

Ejemplares similares

Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice
por: Dwyer, Zach, et al.
Publicado: (2020)

Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity
por: Rudyk, Chris, et al.
Publicado: (2015)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015)

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
por: Maekawa, Tatsunori, et al.
Publicado: (2016)

The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
por: Konstantinidou, Markella, et al.
Publicado: (2020)

Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
por: Baptista, Marco A. S., et al.
Publicado: (2013)

Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
por: Fernández, Belén, et al.
Publicado: (2022)

Chronic unpredictable stress influenced the behavioral but not the neurodegenerative impact of paraquat
por: Rudyk, Chris, et al.
Publicado: (2019)

Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
por: Pungaliya, Pooja P., et al.
Publicado: (2010)

Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
por: Davies, Paul, et al.
Publicado: (2013)

Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor
por: Hanafusa, Hiroshi, et al.
Publicado: (2011)

Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na(+)/K(+) ATPase Activity in Dendritic Cells
por: Hosseinzadeh, Zohreh, et al.
Publicado: (2017)

Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)
por: Beylina, Aleksandra, et al.
Publicado: (2021)

Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy
por: Park, Sangwook, et al.
Publicado: (2016)

Leucine‐rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
por: Mercatelli, Daniela, et al.
Publicado: (2019)

A leucine‐rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls
por: Vissers, Maurits F. J. M., et al.
Publicado: (2023)

LrrkA, a kinase with leucine‐rich repeats, links folate sensing with Kil2 activity and intracellular killing
por: Bodinier, Romain, et al.
Publicado: (2019)

The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4
por: Funk, Natalja, et al.
Publicado: (2019)

Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1
por: Han, Kyung A., et al.
Publicado: (2017)

Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis
por: Ness, Daniel, et al.
Publicado: (2013)

Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response
por: Wandu, Wambui S., et al.
Publicado: (2015)

Age and Chronicity of Administration Dramatically Influenced the Impact of Low Dose Paraquat Exposure on Behavior and Hypothalamic-Pituitary-Adrenal Activity
por: Rudyk, Chris A., et al.
Publicado: (2017)

EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR
por: Ishikawa, Kouki, et al.
Publicado: (2012)

Leucine Rich Repeat Kinase 2 and Innate Immunity
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2020)

Leucine-rich repeat kinase 2 at a glance
por: Zhu, Christiane, et al.
Publicado: (2023)

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression
por: Ho, Dong Hwan, et al.
Publicado: (2015)

Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
por: Pathak, Pragya, et al.
Publicado: (2023)

Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
por: Chen, Kang, et al.
Publicado: (2023)

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression
por: Ho, Dong Hwan, et al.
Publicado: (2017)

Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease
por: Okubadejo, Njideka U., et al.
Publicado: (2018)

The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
por: Rivero-Ríos, Pilar, et al.
Publicado: (2019)

Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution
por: Mamais, Adamantios, et al.
Publicado: (2014)

Parkinson's Disease: Leucine-Rich Repeat Kinase 2 and Autophagy, Intimate Enemies
por: Bravo-San Pedro, José M., et al.
Publicado: (2012)

Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions
por: Greggio, Elisa, et al.
Publicado: (2009)

An extracellular network of Arabidopsis leucine-rich repeat receptor kinases
por: Smakowska-Luzan, Elwira, et al.
Publicado: (2018)

Leucine-Rich Repeat Kinase 2-Linked Parkinson’s Disease: Clinical and Molecular Findings
por: Kumari, Udhaya, et al.
Publicado: (2010)

Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic
por: West, Andrew B
Publicado: (2015)

The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson’s Disease
por: Zhang, Mengfei, et al.
Publicado: (2022)

Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced Neurotoxicity
por: Sim, Joan Poh Ling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_84eed3jgvactulvgd96mhje44i